Apply for Grants
The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Aligning Science Across Parkinson's, 2020Activation of Transposable Elements as a Trigger of Neuroinflammation in Parkinson’s Disease
Study Rationale:
Inflammation is a common event in Parkinson’s disease (PD), but its source remains unclear. There are many candidates that could cause inflammation in the nervous system. One likely... -
Aligning Science Across Parkinson's, 2020Mechanisms of Mitochondrial Damage Control by PINK1 and Parkin
Study Rationale:
Mitochondria are tiny power-generating stations within all cells, including neurons. They are vital energy producers, but when things go wrong, they can spew toxic materials and sicken... -
Aligning Science Across Parkinson's, 2020In Vivo Approach to Elucidate the Pathobiology of Parkinson’s-associated Genes Using Human Diseased Neurons
Study Rationale:
Several genes are known to be associated with Parkinson’s disease, although how they impact the disease process is not fully understood. Here we will use stem cells from patients in... -
Aligning Science Across Parkinson's, 2020Role of PD-related Proteins as Drivers of Disease through Modulation of Innate and Adaptive Immunity
Study Rationale:
The hallmark motor impairments in Parkinson’s disease patients are due to the progressive loss of a special type of neuron in the brain using the chemical messenger dopamine. The... -
Aligning Science Across Parkinson's, 2020Impaired Integration of Organelle Function in Parkinson’s Disease
Study Rationale:
Geneticists have made great progress in identifying gene mutations that either cause Parkinson’s or increase disease risk. The critical next step is to determine how some of these... -
Aligning Science Across Parkinson's, 2020Mapping the LRRK2 Signaling Pathway and Its Interplay with Other Parkinson’s Disease Components
Study Rationale:
Genetic mutations that lead to the activation of the enzyme LRRK2 are a major cause of inherited Parkinson's disease. We aim to combine the complementary expertise of our four research...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.